However, we did not find any correlation between KRAS mutation and KRAS and CTLA-4 mRNA expression in CTCs and primary tumours (KRAS: p = 0.56, CTLA-4: p = 0.24) (Table 3). The gene discussed is KRAS; the disease is neoplasm.